▶ 調査レポート

神経血管塞栓デバイス(神経学)の世界市場:市場規模、シェア、成長、動向、予測

• 英文タイトル:Neurovascular Embolization Devices (Neurology) Market (Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, and Others; Treatment: Ischemic Stroke Solutions and Hemorrhagic Stroke Solutions; Indication: Brain Aneurysms, Arteriovenous Malformation (AVM), and Others; and End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。神経血管塞栓デバイス(神経学)の世界市場:市場規模、シェア、成長、動向、予測 / Neurovascular Embolization Devices (Neurology) Market (Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, and Others; Treatment: Ischemic Stroke Solutions and Hemorrhagic Stroke Solutions; Indication: Brain Aneurysms, Arteriovenous Malformation (AVM), and Others; and End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TPM-NV159資料のイメージです。• レポートコード:TPM-NV159
• 出版社/出版日:Transparency Market Research / 2019年10月28日
• レポート形態:英文、PDF、213ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥631,655 (USD5,795)▷ お問い合わせ
  Multi User¥958,655 (USD8,795)▷ お問い合わせ
  Global Site License¥1,285,655 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、神経血管塞栓デバイス(神経学)の世界市場について調べ、神経血管塞栓デバイス(神経学)の世界市場規模、市場動向、市場シェア、市場環境、市場予測、製品別(塞栓コイル、液体塞栓システム、分流ステント、動脈瘤クリップ、その他)分析、治療別(虚血性脳卒中ソリューションおよび出血性脳卒中ソリューション)分析、疾患別(脳動脈瘤、動静脈奇形(AVM)、およびその他)分析、エンドユーザー別(病院、外来手術センター、専門クリニック)分析、関連企業情報などをまとめました。
・神経血管塞栓デバイス(神経学)の市場概要
・神経血管塞栓デバイス(神経学)の市場動向
・神経血管塞栓デバイス(神経学)の世界市場規模・予測
・神経血管塞栓デバイス(神経学)市場:製品別(塞栓コイル、液体塞栓システム、分流ステント、動脈瘤クリップ、その他)
・神経血管塞栓デバイス(神経学)市場:治療別(虚血性脳卒中ソリューションおよび出血性脳卒中ソリューション)
・神経血管塞栓デバイス(神経学)市場:治療別(虚血性脳卒中ソリューションおよび出血性脳卒中ソリューション)
・神経血管塞栓デバイス(神経学)市場:エンドユーザー別(病院、外来手術センター、専門クリニック)
・地域別分析(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争環境・関連企業分析

Healthcare companies in the neurovascular embolization devices (neurology) market have successfully established a strong foundation for treatment options with the help of embolization coils and liquid embolic systems. However, these treatment options present unique challenges in certain health conditions such as wide-neck bifurcated aneurysms. To overcome this challenge, manufacturers are introducing single-treatment saccular implants. Based on the same principle, healthcare companies in the neurovascular embolization devices (neurology) market are developing Woven EndoBridge (WEB) aneurysm embolization systems that overcome the complications associated with coil-assist devices and surgical clippings.

WEB devices are gaining prominence as a less-invasive treatment alternative for wide-neck intracranial aneurysms in the neurovascular embolization devices (neurology) market space. This is why, many healthcare companies are investing in WEB devices and seeking the approval of health commissions. For instance, in January 2019, MicroVention — a neuroendovascular medical device company, announced the launch of an FDA-approved WEB aneurysm embolization system for the treatment of wide-neck bifurcated aneurysms.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Neurovascular Embolization Devices (Neurology) Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

5.1. Key Industry Developments

5.2. Regulatory Scenario

5.3. Reimbursement Scenario

5.4. Key Mergers & Acquisitions

5.5. Technological Advancements

6. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product

6.1. Introduction & Definition

6.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

6.2.1. Embolization Coils

6.2.2. Liquid Embolic Systems

6.2.3. Flow Diversion Stents

6.2.4. Aneurysm Clips

6.2.5. Others

6.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product

7. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment

7.1. Introduction & Definition

7.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

7.2.1. Ischemic Stroke Solution

7.2.2. Hemorrhagic Stroke Solution

7.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment

8. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication

8.1. Introduction

8.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

8.2.1. Brain Aneurysms

8.2.2. Arteriovenous Malformation (AVM)

8.2.3. Others

8.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication

9. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User

9.1. Introduction

9.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

9.2.1. Hospitals

9.2.2. Ambulatory Surgery Centers

9.2.3. Specialty Clinics

9.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User

10. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Region

10.1. Introduction

10.2. Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Region, 2017–2027

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Region

11. North America Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

11.1. Introduction

11.2. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

11.2.1. Embolization Coils

11.2.2. Liquid Embolic Systems

11.2.3. Flow Diversion Stents

11.2.4. Aneurysm Clips

11.2.5. Others

11.3. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

11.3.1. Ischemic Stroke Solution

11.3.2. Hemorrhagic Stroke Solution

11.4. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

11.4.1. Brain Aneurysms

11.4.2. Arteriovenous Malformation (AVM)

11.4.3. Others

11.5. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

11.5.1. Hospitals

11.5.2. Ambulatory Surgery Centers

11.5.3. Specialty Clinics

11.6. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

11.6.1. U.S.

11.6.2. Canada

11.7. North America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

11.7.1. By Product

11.7.2. By Treatment

11.7.3. By Indication

11.7.4. By End User

11.7.5. By Country/Sub-region

12. Europe Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

12.1. Introduction

12.2. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

12.2.1. Embolization Coils

12.2.2. Liquid Embolic Systems

12.2.3. Flow Diversion Stents

12.2.4. Aneurysm Clips

12.2.5. Others

12.3. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

12.3.1. Ischemic Stroke Solution

12.3.2. Hemorrhagic Stroke Solution

12.4. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

12.4.1. Brain Aneurysms

12.4.2. Arteriovenous Malformation (AVM)

12.4.3. Others

12.5. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

12.5.1. Hospitals

12.5.2. Ambulatory Surgery Centers

12.5.3. Specialty Clinics

12.6. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

12.6.1. Germany

12.6.2. U.K.

12.6.3. France

12.6.4. Spain

12.6.5. Italy

12.6.6. Rest of Europe

12.7. Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

12.7.1. By Product

12.7.2. By Treatment

12.7.3. By Indication

12.7.4. By End User

12.7.5. By Country/Sub-region

13. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

13.1. Introduction

13.2. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

13.2.1. Embolization Coils

13.2.2. Liquid Embolic Systems

13.2.3. Flow Diversion Stents

13.2.4. Aneurysm Clips

13.2.5. Others

13.3. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

13.3.1. Ischemic Stroke Solution

13.3.2. Hemorrhagic Stroke Solution

13.4. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

13.4.1. Brain Aneurysms

13.4.2. Arteriovenous Malformation (AVM)

13.4.3. Others

13.5. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

13.5.1. Hospitals

13.5.2. Ambulatory Surgery Centers

13.5.3. Specialty Clinics

13.6. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

13.6.1. Japan

13.6.2. China

13.6.3. India

13.6.4. Australia & New Zealand

13.6.5. Rest of Asia Pacific

13.7. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

13.7.1. By Product

13.7.2. By Treatment

13.7.3. By Indication

13.7.4. By End User

13.7.5. By Country/Sub-region

14. Latin America Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

14.1. Introduction

14.2. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

14.2.1. Embolization Coils

14.2.2. Liquid Embolic Systems

14.2.3. Flow Diversion Stents

14.2.4. Aneurysm Clips

14.2.5. Others

14.3. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

14.3.1. Ischemic Stroke Solution

14.3.2. Hemorrhagic Stroke Solution

14.4. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

14.4.1. Brain Aneurysms

14.4.2. Arteriovenous Malformation (AVM)

14.4.3. Others

14.5. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

14.5.1. Hospitals

14.5.2. Ambulatory Surgery Centers

14.5.3. Specialty Clinics

14.6. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

14.6.1. Brazil

14.6.2. Mexico

14.6.3. Rest of Latin America

14.7. Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

14.7.1. By Product

14.7.2. By Treatment

14.7.3. By Indication

14.7.4. By End User

14.7.5. By Country/Sub-region

15. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

15.1. Introduction

15.2. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

15.2.1. Embolization Coils

15.2.2. Liquid Embolic Systems

15.2.3. Flow Diversion Stents

15.2.4. Aneurysm Clips

15.2.5. Others

15.3. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

15.3.1. Ischemic Stroke Solution

15.3.2. Hemorrhagic Stroke Solution

15.4. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

15.4.1. Brain Aneurysms

15.4.2. Arteriovenous Malformation (AVM)

15.4.3. Others

15.5. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

15.5.1. Hospitals

15.5.2. Ambulatory Surgery Centers

15.5.3. Specialty Clinics

15.6. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

15.6.1. GCC Countries

15.6.2. South Africa

15.6.3. Rest of Middle East & Africa

15.7. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

15.7.1. By Product

15.7.2. By Treatment

15.7.3. By Indication

15.7.4. By End User

15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Global Neurovascular Embolization Devices (Neurology) Market Share Analysis, by Company (2018)

16.2. Company Profiles

16.2.1. Medtronic plc

16.2.1.1. Company Description

16.2.1.2. Business Overview

16.2.1.3. Financial Overview

16.2.1.4. Strategic Overview

16.2.1.5. SWOT Analysis

16.2.2. Stryker Corporation

16.2.2.1. Company Description

16.2.2.2. Business Overview

16.2.2.3. Financial Overview

16.2.2.4. Strategic Overview

16.2.2.5. SWOT Analysis

16.2.3. DePuy Synthes (Johnson & Johnson Services, Inc.)

16.2.3.1. Company Description

16.2.3.2. Business Overview

16.2.3.3. Financial Overview

16.2.3.4. Strategic Overview

16.2.3.5. SWOT Analysis

16.2.4. B.Braun Melsungen AG

16.2.4.1. Company Description

16.2.4.2. Business Overview

16.2.4.3. Financial Overview

16.2.4.4. Strategic Overview

16.2.4.5. SWOT Analysis

16.2.5. Penumbra, Inc.

16.2.5.1. Company Description

16.2.5.2. Business Overview

16.2.5.3. Financial Overview

16.2.5.4. Strategic Overview

16.2.5.5. SWOT Analysis

16.2.6. Acandis GmbH

16.2.6.1. Company Description

16.2.6.2. Business Overview

16.2.6.3. Financial Overview

16.2.6.4. Strategic Overview

16.2.6.5. SWOT Analysis

16.2.7. BALT EXTRUSION

16.2.7.1. Company Description

16.2.7.2. Business Overview

16.2.7.3. Financial Overview

16.2.7.4. Strategic Overview

16.2.7.5. SWOT Analysis

16.2.8. Terumo Medical Corporation

16.2.8.1. Company Description

16.2.8.2. Business Overview

16.2.8.3. Financial Overview

16.2.8.4. Strategic Overview

16.2.8.5. SWOT Analysis

16.2.9. Boston Scientific Corporation

16.2.9.1. Company Description

16.2.9.2. Business Overview

16.2.9.3. Financial Overview

16.2.9.4. Strategic Overview

16.2.9.5. SWOT Analysis

16.2.10. Spartan Micro, Inc.

16.2.10.1. Company Description

16.2.10.2. Business Overview

16.2.10.3. Financial Overview

16.2.10.4. Strategic Overview

16.2.10.5. SWOT Analysis